Frontier IP Group plc Royal Society of Chemistry Nominations
09 May 2017 - 9:05PM
RNS Non-Regulatory
TIDMFIPP
Frontier IP Group plc
09 May 2017
RNS REACH
AIM: FIPP
9 May 2017
Frontier IP Group Plc
("Frontier IP" or the "Group")
Three Group nominations for Royal Society of Chemistry
awards
Frontier IP, which specialises in the commercialisation of
intellectual property, is pleased to announce that two of its
portfolio companies, Alusid Limited ("Alusid") and Exscientia
Limited ("Exscientia") have received nominations for a total of
three awards at the Royal Society of Chemistry's forthcoming
Chemistry World flagship event in June.
Alusid has been shortlisted for the Emerging Technologies
competition for its multi-award winning Architectural surfacing
Eco-materials, made from fused recycled glass and ceramics using a
low energy process, designed as an adaptable alternative to natural
stone. Alusid aims to be a leader in the supply of premium
engineered sustainable architectural materials and remains at the
forefront of this growing sector through continuous research and
development.
Exscientia is at the forefront of small molecule drug discovery.
It applies a wealth of AI techniques to automate drug design in a
manner that surpasses conventional human endeavour. In just three
years Exscientia has already grown a portfolio of global
collaborations that include Sanofi, Sumitomo Dainippon and
Sunovion. Exscientia sees two of its staff shortlisted to the final
three, Andrew Hopkins, as Chemistry World Entrepreneur of the Year
and Jérémy Besnard for the Rising Star in Industry Award.
Neil Crabb, CEO of Frontier IP, commented "It is pleasing to see
both companies continuing to garner recognition for the excellence
of their technologies and people as they drive commercial success
in their respective marketplaces".
ENDS
For further information:
Frontier IP Group Plc T: 0131 240 1251
Neil Crabb, Chief Executive
Company website: www.frontierip.co.uk
Cenkos Securities plc (Nominated T: 0131 220 6939
Adviser and Joint Broker)
Neil McDonald / Beth McKiernan
Peterhouse Corporate Finance T: 020 7469 0935
Limited (Joint Broker)
Lucy Williams
Kreab (Financial PR) T: 020 7074 1800
Robert Speed / Matthew Jervois
Notes to Editor:
About Frontier IP Group plc
www.frontierip.co.uk.
Frontier IP specialises in assisting institutions and companies
in the commercialisation and exploitation of their intellectual
property. It establishes formal and informal relationships with
sources of exploitable IP, principally universities. Its core
business is building and growing a portfolio of equity stakes in
spin-out companies by taking an active involvement in the
commercialisation and funding of these businesses.
About Alusid
www.alusid.co.uk
ALUSID - a university spinoff company - was born from a research
project led by Professor David Binns and Dr Alasdair Bremner, at
the University of Central Lancashire. Alusid aims to be a leader in
the supply of premium engineered sustainable architectural
materials and remains at the forefront of this growing sector
through continuous research and development.
About Exscientia
www.exscientia.co.uk
Exscientia is at the forefront of Artificial Intelligence
(AI)-driven drug discovery and design. By fusing the power of AI
with the discovery experience of seasoned drug hunters, it is the
first company to automate drug design, surpassing conventional
approaches. Its innovative platform enables breakthrough
productivity gains with new approaches to improve drug efficacy. It
is delivering a pipeline of efficacious, bispecific small
molecules, as well as highly selective single target candidates,
for multiple indications.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAFKLFBDEFBBBX
(END) Dow Jones Newswires
May 09, 2017 07:05 ET (11:05 GMT)
Frontier Ip (LSE:FIPP)
Historical Stock Chart
From Apr 2024 to May 2024
Frontier Ip (LSE:FIPP)
Historical Stock Chart
From May 2023 to May 2024